Interdisciplinary model‐informed drug development for extending duration of elagolix treatment in patients with uterine fibroids-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Interdisciplinary model‐informed drug development for extending duration of elagolix treatment in patients with uterine fibroids

Published:2022-07-11 Issue:12 Volume:88 Page:5257-5268
ISSN:0306-5251
Container-title:British Journal of Clinical Pharmacology
language:en
Short-container-title:Brit J Clinical Pharma

Author:

Beck Denise¹,Winzenborg Insa¹^ORCID,Gao Wei²,Mostafa Nael M.³,Chiuve Stephanie E.⁴,Owens Charlotte⁵,Shebley Mohamad³^ORCID

Affiliation:

1. Clinical Pharmacology and Pharmacometrics AbbVie Deutschland GmbH & Co. KG Ludwigshafen am Rhein Germany

2. Analysis Group, Inc. Boston USA

3. Clinical Pharmacology and Pharmacometrics, AbbVie North Chicago IL USA

4. Global Epidemiology, AbbVie North Chicago IL USA

5. Clinical Development, General Medicine, AbbVie North Chicago IL USA

Funder

AbbVie

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bcp.15440

Reference40 articles.

1. The impact of uterine leiomyomas: a national survey of affected women

2. Beyond the physical: A qualitative assessment of the burden of symptomatic uterine fibroids on women's emotional and psychosocial health

3. Achieving clinically meaningful response in endometriosis pain symptoms is associated with improvements in health-related quality of life and work productivity: analysis of 2 phase III clinical trials

4. Long-Term Outcomes of Elagolix in Women With Endometriosis

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. GnRH agonists and antagonists in therapy of symptomatic uterine fibroids – current roles and future perspectives;Expert Opinion on Pharmacotherapy;2023-08-24

2. Contemporary approaches in the management of uterine leiomyomas;European Journal of Obstetrics & Gynecology and Reproductive Biology;2023-08

3. Modeling tumor size dynamics based on real‐world electronic health records and image data in advanced melanoma patients receiving immunotherapy;CPT: Pharmacometrics & Systems Pharmacology;2023-06-16

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3